Experimental acute otitis media due to nontypeable Haemophilus influenzae: Comparison of high and low azithromycin doses with placebo

Antimicrobial Agents and Chemotherapy

Volumn 46, Issue 7, 2002, Pages 2194-2199

  Babl, Franz E ^a   Pelton, Stephen I ^a   Li, Zhong ^a  

^a BOSTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; PLACEBO;

ACUTE DISEASE; ANIMAL MODEL; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; CHINCHILLA; CONTROLLED STUDY; DOSE RESPONSE; EXPERIMENTAL MODEL; HAEMOPHILUS INFLUENZAE; MIDDLE EAR DISEASE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OTITIS MEDIA; PRIORITY JOURNAL; TREATMENT OUTCOME; ANIMAL; BLOOD; COMPARATIVE STUDY;

ACUTE DISEASE; ANIMAL; AZITHROMYCIN; CHINCHILLA; COMPARATIVE STUDY; DOSE-RESPONSE RELATIONSHIP, DRUG; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE; OTITIS MEDIA; SUPPORT, NON-U.S. GOV'T; ANIMALS;

EID: 0035984792     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.46.7.2194-2199.2002     Document Type: Article

References (25)

1. A multicenter, open label trial of azithromycin vs. amoxicillin-clavulanate for the management of acute otitis media in children
2. Causative pathogens, antibiotic resistance and therapeutic considerations in acute otitis media
3. Therapeutic approaches to experimental otitis media due to penicillin-resistant Streptococcus pneumoniae
4. Host factors and early therapeutic response in acute otitis media
5. Efficacy of a new macrolide (azithromycin). For acute otitis media in the chinchilla model
6. Bacteriologic and clinical efficacy of amoxicillin/clavulanate vs. azithromycin in acute otitis media
7. Bacteriologic efficacies of oral azithromycin and oral cefaclor in treatment of acute otitis media in infants and young children
8. Early eradication of pathogens from middle ear fluid during antibiotic treatment of acute otitis media is associated with improved clinical outcome
9. Otitis media: The chinchilla model
10. Correlation of increased azithromycin concentrations with phagocyte infiltration into sites of localized infection
11. In vitro and in vivo uptake of azithromycin (CP-62 993) by phagocytic cells: Possible mechanism of delivery and release at sites of infection
12. Pharmacokinetic and clinical evaluation of azithromycin in pediatric infections
13. Modification of otitis media in chinchillas rechallenged with nontypable Haemophilus influenzae and serological response to outer membrane antigens
14. A multicenter, randomized, open label comparison of azithromycin and amoxicillin-clavulanate in acute otitis media among children attending day care or school
15. A multicenter, double blind comparison of azithromycin and amoxicillin-clavulanate for the treatment of acute otitis media in children
16. A comparative study of azithromycin and amoxycillin in pediatric patients with acute otitis media
17. Is the pneumococcus the one and only in acute otitis media?
18. Pharmacokinetics of azithromycin in pediatric patients with acute otitis media
19. Pharmacokinetics of azithromycin administered alone and with atovaquone in human immunodeficiency virus-infected children
20. Efficacy of linezolid in experimental otitis media
21. Multicentre comparative study of the efficacy and safety of azithromycin compared with amoxicillin-clavulanic acid in the treatment of pediatric patients with otitis media
22. Interpretation of middle ear fluid concentrations of antibiotics: Comparison between ceftibuten, cefixime and azithromycin
23. Multicentre evaluation of azithromycin in comparison with co-amoxiclav for the treatment of acute otitis media in children
24. Pharmacokinetics of azithromycin after single- and multiple-doses in children